Sudler & Hennessey (S&H) has been selected by AstraZeneca as the global agency partner of record for the developmental arthritis treatment PN400.

AstraZeneca is going for the jugular - or rather, the carotid - with new ads emphasizing Crestor's effectiveness at slowing the progression of atherosclerosis.

David Paragamian emphasizes the importance of building master brands and exploring promotional channels

AstraZeneca's Nexium could face generic competition much sooner than expected, and would-be investors should be wary, said brokerage firm Sanford C. Bernstein in an analyst note.

Pharmaceutical manufacturers increased wholesale prices for the 50 top-selling branded medications by an average of 7.82% in 2007, after increases of 6.73% and 6.22% in the previous two years, according to data from marketing research firm Delta Marketing Dynamics.

Australia's drug and medical device regulatory agency, the Therapeutic Goods Administration (TGA), has issued a warning concerning nail fungus treatment Lamisil (terbinafine) tablets following reports of three deaths and severe liver reactions among patients.

NitroMed announced it plans to lay off a majority of its newly hired BiDil sales force by roughly 70 to 90 employees.

GlaxoSmithKline should be finished transitioning the media planning and buying for its North American OTC business by the end of February, a spokesperson for the drugmaker said.

MM&M's New Drug Dossier is designed to give pharmaceutical marketers authoritative promotional and clinical insights on the latest new molecular entities in one online resource.

Roche has accepted the recommendation of an FDA panel to place a stronger warning on its flu treatment Tamiflu, the Associated Press reports.